An Influence of Menopausal Symptoms on Mental Health, Emotion Perception, and Quality of Life: a Multi-faceted Approach

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2024 May 3

PMID 38700754

Authors

Sven C Mueller

Marta De Franceschi

Julia Brzozowska

Aleksandra M Herman

Marco Ninghetto

Kalina Burnat

Monika Grymowicz

Artur Marchewka

Affiliations

Soon will be listed here.

Abstract

Purpose: The menopausal transition brings with it many physical, cognitive, and affective changes in a woman's life, impacting quality of life. Whereas prior work has examined impact on general mental health and cognitive function, research on basic affective processing during menopause remains scarce.

Methods: Using a median-split procedure, this pre-registered study examined the impact of stronger (N = 46 women) vs. milder (N = 47 women) menopausal symptoms using a behavioural task of subjective emotion perception (embody) and a passive eye tracking viewing task of emotional faces in addition to self-report questionnaires. After 3 months, participants completed the questionnaires again to examine whether objective measures of emotion perception (eye tracking) might predict mental health at follow-up.

Results: As anticipated, women with stronger vs. milder menopausal symptoms reported increased symptoms of anxiety, depression, stress, emotion regulation difficulties, and lower quality of life during both time points. While no evidence was found in the behavioural task, eye tracking data indicated blunted emotion perception in women with high menopausal symptoms, while women with low symptoms spent more time looking at happy faces relative to fearful or surprised faces. Although eye tracking or hormonal data did not predict mental health at follow-up, a higher estradiol/FSH ratio indicated a higher quality of life.

Conclusions: This study documented an impact of the menopausal transition and strength of menopausal symptoms in particular on objective emotion perception as well as mental health and quality of life in women suffering from stronger vs. milder menopausal symptoms. Clinical implications are discussed.

References

Schmidt P . Mood, depression, and reproductive hormones in the menopausal transition. Am J Med. 2006; 118 Suppl 12B:54-8. DOI: 10.1016/j.amjmed.2005.09.033. View

Gallicchio L, Schilling C, Miller S, Zacur H, Flaws J . Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res. 2007; 63(3):263-8. DOI: 10.1016/j.jpsychores.2007.02.003. View

Schneider H, Birkhauser M . Quality of life in climacteric women. Climacteric. 2017; 20(3):187-194. DOI: 10.1080/13697137.2017.1279599. View

Whiteley J, DiBonaventura M, Wagner J, Alvir J, Shah S . The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt). 2013; 22(11):983-90. PMC: 3820128. DOI: 10.1089/jwh.2012.3719. View

Keye C, Varley J, Patton D . The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis. Climacteric. 2023; 26(5):419-427. DOI: 10.1080/13697137.2023.2226318. View

Rodrigo C, Sebire E, Bhattacharya S, Paranjothy S, Black M . Effectiveness of workplace-based interventions to promote wellbeing among menopausal women: A systematic review. Post Reprod Health. 2023; 29(2):99-108. PMC: 10273852. DOI: 10.1177/20533691231177414. View

Hashiguchi K, Yoshikawa S, Muto T . Emotion regulation processes and middle-aged Japanese women's health. Climacteric. 2020; 24(2):200-205. DOI: 10.1080/13697137.2020.1784135. View

Berent-Spillson A, Marsh C, Persad C, Randolph J, Zubieta J, Smith Y . Metabolic and hormone influences on emotion processing during menopause. Psychoneuroendocrinology. 2016; 76:218-225. PMC: 5272799. DOI: 10.1016/j.psyneuen.2016.08.026. View

Nummenmaa L, Glerean E, Hari R, Hietanen J . Bodily maps of emotions. Proc Natl Acad Sci U S A. 2014; 111(2):646-51. PMC: 3896150. DOI: 10.1073/pnas.1321664111. View

10.

Herman A, Zaremba D, Kossowski B, Marchewka A . The utility of the emBODY tool as a novel method of studying complex phenomena-related emotions. Sci Rep. 2022; 12(1):19884. PMC: 9674849. DOI: 10.1038/s41598-022-23734-4. View

11.

Lazarov A, Ben-Zion Z, Shamai D, Pine D, Bar-Haim Y . Free viewing of sad and happy faces in depression: A potential target for attention bias modification. J Affect Disord. 2018; 238:94-100. PMC: 6310000. DOI: 10.1016/j.jad.2018.05.047. View

12.

Isaac L, Vrijsen J, Rinck M, Speckens A, Becker E . Shorter gaze duration for happy faces in current but not remitted depression: evidence from eye movements. Psychiatry Res. 2014; 218(1-2):79-86. DOI: 10.1016/j.psychres.2014.04.002. View

13.

Suslow T, Hoepfel D, Gunther V, Kersting A, Bodenschatz C . Positive attentional bias mediates the relationship between trait emotional intelligence and trait affect. Sci Rep. 2022; 12(1):20733. PMC: 9715682. DOI: 10.1038/s41598-022-25317-9. View

14.

Kinner V, Kuchinke L, Dierolf A, Merz C, Otto T, Wolf O . What our eyes tell us about feelings: Tracking pupillary responses during emotion regulation processes. Psychophysiology. 2017; 54(4):508-518. DOI: 10.1111/psyp.12816. View

15.

Henderson R, Bradley M, Lang P . Emotional imagery and pupil diameter. Psychophysiology. 2017; 55(6):e13050. PMC: 5940515. DOI: 10.1111/psyp.13050. View

16.

Price R, Rosen D, Siegle G, Ladouceur C, Tang K, Allen K . From anxious youth to depressed adolescents: Prospective prediction of 2-year depression symptoms via attentional bias measures. J Abnorm Psychol. 2015; 125(2):267-278. PMC: 4747845. DOI: 10.1037/abn0000127. View

17.

Hershman R, Henik A, Cohen N . CHAP: Open-source software for processing and analyzing pupillometry data. Behav Res Methods. 2019; 51(3):1059-1074. DOI: 10.3758/s13428-018-01190-1. View

18.

Schneider H, Heinemann L, Rosemeier H, Potthoff P, Behre H . The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric. 2002; 3(1):59-64. DOI: 10.3109/13697130009167600. View

19.

Heinemann L, Dominh T, Strelow F, Gerbsch S, Schnitker J, Schneider H . The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes. 2004; 2:67. PMC: 534786. DOI: 10.1186/1477-7525-2-67. View

20.

Maier W, Buller R, Philipp M, Heuser I . The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988; 14(1):61-8. DOI: 10.1016/0165-0327(88)90072-9. View